DNAprint Genomics (DNAG)

[stakddek]

Okay Arch. I guess we still don't "get no respect". The Forbes story didn't mention DNAP by name. What do we have to do? Raise the share price and be listed on another exchange? Tie in with patents from a high profile institution? Lease a few test regimes to a big pharma? What's gotta' be gotta' be. The only drawback to all this is of course the takeover card. If someone can acquire enough stock, what protects us from a hostile buyout?

Okay I thought about this consolidation. I've put my trust in Doctor Frudakis for this long that I see no reason to change. I have some mixed feelings about the management team but then if they are wheeling dealing, I am along for the ride. I don't believe Doctor Frudakis would let them kill his dreams or ours. They managers may make money on any deal they construct, and we may just get crumbs, and I don't like that, but it's still progress. There is a very good chance that the crumbs that fall our way from the royal table may be quite nutricious.

Let it ride!

Stakddek